0001140361-21-014360.txt : 20210426
0001140361-21-014360.hdr.sgml : 20210426
20210426185642
ACCESSION NUMBER: 0001140361-21-014360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210426
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ocko Matthew
CENTRAL INDEX KEY: 0001836089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40354
FILM NUMBER: 21855426
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zymergen Inc.
CENTRAL INDEX KEY: 0001645842
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 462942439
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6121 HOLLIS STREET, SUITE 700
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (415) 801-8073
MAIL ADDRESS:
STREET 1: 6121 HOLLIS STREET, SUITE 700
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Zymergen, Inc.
DATE OF NAME CHANGE: 20150622
4
1
form4.xml
FORM 4
X0306
4
2021-04-26
0001645842
Zymergen Inc.
ZY
0001836089
Ocko Matthew
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
true
Common Stock
2021-04-26
4
C
0
210450
A
210450
I
See footnote
Common Stock
2021-04-26
4
C
0
2936283
A
2936283
I
See footnote
Common Stock
2021-04-26
4
C
0
2014506
A
2224956
I
See footnote
Common Stock
2021-04-26
4
C
0
1687050
A
4623333
I
See footnote
Common Stock
2021-04-26
4
C
0
294401
A
4917734
I
See footnote
Common Stock
2021-04-26
4
C
0
223945
A
2448901
I
See footnote
Series A Preferred Stock
2021-04-26
4
C
0
210450
0
D
Common Stock
210450
0
I
See footnote
Series A Preferred Stock
2021-04-26
4
C
0
2936283
0
D
Common Stock
2936283
0
I
See footnote
Series A-1 Preferred Stock
2021-04-26
4
C
0
2014506
0
D
Common Stock
2014506
0
I
See footnote
Series B Preferred Stock
2021-04-26
4
C
0
1684397
0
D
Common Stock
1687050
0
I
See footnote
Series C Preferred Stock
2021-04-26
4
C
0
294401
0
D
Common Stock
294401
0
I
See footnote
Series D Preferred Stock
2021-04-26
4
C
0
223945
0
D
Common Stock
223945
0
I
See footnote
Each share of Series A, Series A-1, Series C and Series D Preferred Stock converted automatically into one share of the Issuer's common stock for no additional consideration upon the completion of the Issuer's initial public offering and has no expiration date.
Each share of Series B Preferred Stock converted automatically into 1.0015 shares of the Issuer's common stock for no additional consideration upon the completion of the Issuer's initial public offering and has no expiration date.
Represents shares held of record by Data Collective II, L.P. ("DCVC II"). Data Collective II GP, LLC ("DCVC II GP") is the general partner of DCVC II and has sole voting and dispositive power with regard to the shares held by DCVC II. The Reporting Person is a managing member of DCVC II GP and shares voting and dispositive power with respect to the shares held by DCVC II. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of such shares and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares, except to the extent of his indirect pecuniary interest therein, if any.
Represents shares held of record by DCVC Opportunity Fund, L.P. ("DCVC Opportunity Fund"). DCVC Opportunity Fund GP, LLC ("DCVC Opportunity Fund GP") is the general partner of DCVC Opportunity Fund and has sole voting and dispositive power with regard to the shares held by DCVC Opportunity Fund. The Reporting Person is a managing member of DCVC Opportunity Fund GP and shares voting and dispositive power with respect to the shares held by DCVC Opportunity Fund. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of such shares and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares, except to the extent of his indirect pecuniary interest therein, if any.
/s/ Mina Kim, attorney-in-fact for Matthew Ocko
2021-04-26